ATE538201T1 - Kcnb: ein kaliumkanalprotein - Google Patents

Kcnb: ein kaliumkanalprotein

Info

Publication number: ATE538201T1
Authority: AT; Austria
Prior art keywords: kcnb; potassium channel; channel protein; activity; modulate
Prior art date: 2000-03-03

Application number

AT01924111T

Other languages

English (en)

Inventor

David Mu

Scott Powers

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-03

Filing date

2001-03-02

Publication date

2012-01-15

2001-03-02 Application filed by Amgen Inc filed Critical Amgen Inc

2012-01-15 Application granted granted Critical

2012-01-15 Publication of ATE538201T1 publication Critical patent/ATE538201T1/de

Links

102000004257 Potassium Channel Human genes 0.000 title abstract 2
108020001213 potassium channel Proteins 0.000 title abstract 2
241000124008 Mammalia Species 0.000 abstract 1
108091005461 Nucleic proteins Chemical group 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
150000007523 nucleic acids Chemical group 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
238000011895 specific detection Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Cell Biology (AREA)
Immunology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Psychology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Peptides Or Proteins (AREA)
Obesity (AREA)

AT01924111T 2000-03-03 2001-03-02 Kcnb: ein kaliumkanalprotein ATE538201T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US18691500P	2000-03-03	2000-03-03
PCT/US2001/006801 WO2001066741A2 (en)	2000-03-03	2001-03-02	Kcnb: a novel potassium channel protein

Publications (1)

Publication Number	Publication Date
ATE538201T1 true ATE538201T1 (de)	2012-01-15

Family

ID=22686808

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01924111T ATE538201T1 (de)	2000-03-03	2001-03-02	Kcnb: ein kaliumkanalprotein

Country Status (12)

Country	Link
US (2)	US7462465B2 (de)
EP (1)	EP1266003B1 (de)
JP (2)	JP2004500825A (de)
CN (1)	CN1426468A (de)
AT (1)	ATE538201T1 (de)
AU (2)	AU2001250794B2 (de)
CA (1)	CA2401906C (de)
ES (1)	ES2378417T3 (de)
IL (2)	IL151564A0 (de)
NZ (1)	NZ521205A (de)
WO (1)	WO2001066741A2 (de)
ZA (1)	ZA200206999B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1471922A4 (de) *	2001-12-31	2007-03-07	Algos Therapeutics Inc	Verfahren und materialien zur modulation von task-3
WO2005052586A2 (en) *	2003-11-27	2005-06-09	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 3 (kcnk3)
WO2005075510A1 (en) *	2004-02-04	2005-08-18	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 9 (kcnk9)
US12416024B2 (en)	2018-03-29	2025-09-16	Transworld Technologies Inc.	Biologically enhanced oil recovery methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2744730B1 (fr)	1996-02-08	1998-04-17	Centre Nat Rech Scient	Nouvelle famille de canaux potassium de mammifere, leur clonage et leur utilisation notamment pour le criblage de drogues
JP2002511233A (ja)	1998-01-27	2002-04-16	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	Ｔｒｅｋ１様の２孔カリウムチャネル
WO2000000610A2 (en)	1998-06-26	2000-01-06	Incyte Pharmaceuticals, Inc.	Human signal peptide-containing proteins
ES2307343T3 (es)	1998-11-09	2008-11-16	Centre National De La Recherche Scientifique (Cnrs)	Nueva familia de canales de potasio de mamiferos, su clonacion y su uso, particularmente para el escrutinio de farmacos.
JP2002542765A (ja) *	1999-03-05	2002-12-17	スミスクラインビーチャムパブリックリミテッドカンパニー	新規化合物
US20020137202A1 (en) *	1999-12-21	2002-09-26	Catherine Burgess	Novel proteins and nucleic acids encoding same
US20020081590A1 (en)	2000-02-04	2002-06-27	Aeomica, Inc.	Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
JP2004507218A (ja)	2000-04-06	2004-03-11	インサイト・ゲノミックス・インコーポレイテッド	輸送体及びイオンチャネル
WO2002026983A2 (en)	2000-09-25	2002-04-04	Millennium Pharmaceuticals, Inc.	56115, a novel human twik potassium channel and uses therefor

2001
- 2001-03-02 JP JP2001565895A patent/JP2004500825A/ja active Pending
- 2001-03-02 ES ES01924111T patent/ES2378417T3/es not_active Expired - Lifetime
- 2001-03-02 AT AT01924111T patent/ATE538201T1/de active
- 2001-03-02 US US09/798,584 patent/US7462465B2/en not_active Expired - Fee Related
- 2001-03-02 CN CN01808748A patent/CN1426468A/zh active Pending
- 2001-03-02 AU AU2001250794A patent/AU2001250794B2/en not_active Ceased
- 2001-03-02 IL IL15156401A patent/IL151564A0/xx unknown
- 2001-03-02 CA CA2401906A patent/CA2401906C/en not_active Expired - Lifetime
- 2001-03-02 EP EP01924111A patent/EP1266003B1/de not_active Expired - Lifetime
- 2001-03-02 AU AU5079401A patent/AU5079401A/xx active Pending
- 2001-03-02 NZ NZ521205A patent/NZ521205A/en unknown
- 2001-03-02 WO PCT/US2001/006801 patent/WO2001066741A2/en not_active Ceased
2002
- 2002-08-30 ZA ZA200206999A patent/ZA200206999B/en unknown
- 2002-09-02 IL IL151564A patent/IL151564A/en not_active IP Right Cessation
2008
- 2008-01-03 US US11/968,795 patent/US20080234470A1/en not_active Abandoned
2011
- 2011-01-13 JP JP2011005342A patent/JP2011115169A/ja active Pending

Also Published As

Publication number	Publication date
IL151564A0 (en)	2003-04-10
AU5079401A (en)	2001-09-17
AU2001250794B2 (en)	2006-03-02
NZ521205A (en)	2005-09-30
EP1266003B1 (de)	2011-12-21
WO2001066741A2 (en)	2001-09-13
IL151564A (en)	2008-11-03
US20080234470A1 (en)	2008-09-25
WO2001066741A9 (en)	2003-03-06
CA2401906C (en)	2011-07-19
EP1266003A2 (de)	2002-12-18
JP2011115169A (ja)	2011-06-16
ES2378417T3 (es)	2012-04-12
ZA200206999B (en)	2004-05-31
CN1426468A (zh)	2003-06-25
CA2401906A1 (en)	2001-09-13
JP2004500825A (ja)	2004-01-15
US20020102676A1 (en)	2002-08-01
US7462465B2 (en)	2008-12-09
WO2001066741A3 (en)	2002-04-04

Publication	Publication Date	Title
DE60330842D1 (de)	2010-02-25	Für den nachweis von nukleinsäuren kompetente biologische rohderivate
DE60322880D1 (de)	2008-09-25	Einfache katalytische dna-biosensoren für ionen auf grundlage von farbveränderungen
DE60023936D1 (de)	2005-12-15	Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
SE0003286D0 (sv)	2000-09-15	Method and kit for human identification
DE60041355D1 (de)	2009-02-26	Verfahren zur detektion von erkrankungen
ATE393228T1 (de)	2008-05-15	Fusionsproteine und deren verwendung zur messung von protease-aktivität
DK1268847T3 (da)	2008-03-10	Ubiquitin-ligaseassay
ATE419388T1 (de)	2009-01-15	Nukleinsäureanreicherung
ATE500323T1 (de)	2011-03-15	Subtilisin-variante
DE69937835D1 (de)	2008-02-07	Antikörper für apoptosemarker und anwendungsverfahren
DK1399590T3 (da)	2006-09-18	Happier kortlægning
BRPI0001536A (pt)	2001-12-04	método para diagnosticar a infecção por parasitos do genero schistosoma e kit para uso no diagnóstico da infecção por schistosoma sp
ATE439441T1 (de)	2009-08-15	Veränderte, fluoreszierende proteine
TR200200667T2 (tr)	2002-06-21	Leu-hirudinin E.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları.
ATE389881T1 (de)	2008-04-15	Detektion von kleinen molekülen mit piezo- elektrischem sensor
ATE389018T1 (de)	2008-03-15	Cx3c chemokin-gene von säugetieren
ATE288589T1 (de)	2005-02-15	Verfahren zur analyse von proteinen
AU5079401A (en)	2001-09-17	Kcnb: a novel potassium channel protein
ATE456666T1 (de)	2010-02-15	Verfahren zur auswertung von ribonukleotidsequenzen
Li et al.	2000	Possible release of an ArgGlyArgProGln pentapeptide with innate immunity properties from acidic proline-rich proteins by proteolytic activity in commensal Streptococcus and Actinomyces species
DE69734586D1 (de)	2005-12-15	Retinoid-metabolisierendes protein
ATE280836T1 (de)	2004-11-15	Test zur gleichzeitigen messung von verschiedenen enzymatischen aktivitäten
ATE333519T1 (de)	2006-08-15	Electrochemisches verfahren zum nachweis von nukleinsäuren
BR0108767A (pt)	2002-12-03	Adenilciclase recombinante, polinucleotìdeo, vetor, processos para a detecção de atividade proteolìtica de uma molécula e da resistência a um inibidor, de uma molécula com atividade proteolìtica e de identificação de moléculas com atividade proteolìtica sìtio-especìfica, kit de diagnóstico, utilização de uma adenilciclase, e, cepa bacteriana
ATE409742T1 (de)	2008-10-15	Von bacillus cereus produzierte cereulid-synthase,diese codierendes gen und verfahren zum nachweis von cereulid